Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million

Reuters
·
Jun 23

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 5.19 million in common shares

Reuters
·
Jun 18

United Therapeutics CFO, Treasurer James Edgemond disposes of USD 9.12 million in common shares

Reuters
·
Jun 17

United Therapeutics Chairperson, CEO Martine Rothblatt sells $4.9 million in common shares

Reuters
·
Jun 16

United Therapeutics CFO James Edgemond disposes of common shares worth $5.42 million

Reuters
·
Jun 13

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of common shares worth $5.17 million

Reuters
·
Jun 13

Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)

TIPRANKS
·
Jun 12

United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 8,500 common shares worth $4.65 million

Reuters
·
Jun 12

United Therapeutics CFO James Edgemond disposes of USD 5.47 million in common shares

Reuters
·
Jun 10

United Therapeutics CEO Chairperson Martine Rothblatt disposes of common shares worth $5.2 million

Reuters
·
Jun 10

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.19 million

Reuters
·
Jun 09

United Therapeutics CFO James Edgemond disposes of 8,000 shares worth $4.36 million

Reuters
·
Jun 06

United Therapeutics Chairperson and CEO Martine Rothblatt reports UTHR share disposal worth $4.25 million

Reuters
·
Jun 06

Will Positive TETON-1 IPF Data and Space R&D Shift United Therapeutics' (UTHR) Innovation Narrative?

Simply Wall St.
·
Jun 06

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Fate Therapeutics (FATE) and Edgewise Therapeutics (EWTX)

TIPRANKS
·
Jun 06

United Therapeutics EVP, General Counsel Paul A. Mahon disposes of common shares worth $4.68 million

Reuters
·
Jun 05

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.1 million

Reuters
·
Jun 04

United Therapeutics CFO James Edgemond disposes of common shares worth $4.87 million

Reuters
·
Jun 03

United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.75 million in common shares

Reuters
·
Jun 02

United Therapeutics CFO James Edgemond disposes of 10,000 common shares worth $5.66 million

Reuters
·
May 30